Bouvel Investment Partners, LLC Adaptive Biotechnologies Corp Transaction History

Bouvel Investment Partners, LLC

$227 Million
Q1 2025

A detailed history of Bouvel Investment Partners, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Bouvel Investment Partners, LLC holds 43,882 shares of ADPT stock, worth $533,605. This represents 0.14% of its overall portfolio holdings.

Number of Shares

43,882

Previous 43,805 0.18%

Holding current value

$533,605

Previous $262,000 24.43%

% of portfolio

0.14%

Previous 0.1%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	BUY	$6.07 - $8.66 $467 - $666	77 Added 0.18%	43,882 $326,000
Q4 2024 Jan 14, 2025	SELL	$4.37 - $6.78 $336 - $522	-77 Reduced 0.18%	43,805 $262,000
Q3 2024 Nov 05, 2024	SELL	$3.37 - $5.12 $6,733 - $10,229	-1,998 Reduced 4.35%	43,882 $224,000
Q2 2024 Jul 12, 2024	SELL	$2.34 - $3.96 $351 - $594	-150 Reduced 0.33%	45,880 $166,000
Q1 2024 Apr 15, 2024	BUY	$2.88 - $4.8 $2,390 - $3,984	830 Added 1.84%	46,030 $147,000
Q4 2023 Jan 11, 2024	BUY	$3.46 - $5.33 $3,463 - $5,335	1,001 Added 2.26%	45,200 $221,000
Q3 2023 Oct 10, 2023	BUY	$5.07 - $8.44 $1,906 - $3,173	376 Added 0.86%	44,199 $240,000
Q2 2023 Jul 14, 2023	BUY	$6.19 - $8.78 $8,610 - $12,212	1,391 Added 3.28%	43,823 $294,000
Q1 2023 Apr 11, 2023	BUY	$7.8 - $10.11 $9,672 - $12,536	1,240 Added 3.01%	42,432 $374,000
Q4 2022 Jan 18, 2023	BUY	$6.26 - $9.34 $9,602 - $14,327	1,534 Added 3.87%	41,192 $0
Q3 2022 Oct 13, 2022	BUY	$6.5 - $12.67 $163,527 - $318,751	25,158 Added 173.5%	39,658 $282,000
Q2 2022 Jul 13, 2022	BUY	$6.4 - $14.73 $723 - $1,664	113 Added 0.79%	14,500 $117,000
Q1 2022 Apr 11, 2022	BUY	$10.12 - $28.9 $910 - $2,601	90 Added 0.63%	14,387 $200,000
Q4 2021 Jan 19, 2022	SELL	$25.17 - $36.85 $4,354 - $6,375	-173 Reduced 1.2%	14,297 $401,000
Q3 2021 Oct 07, 2021	SELL	$30.02 - $39.87 $7,234 - $9,608	-241 Reduced 1.64%	14,470 $492,000
Q2 2021 Jul 12, 2021	BUY	$32.22 - $44.59 $2,416 - $3,344	75 Added 0.51%	14,711 $601,000
Q1 2021 Apr 16, 2021	SELL	$37.26 - $67.74 $1,751 - $3,183	-47 Reduced 0.32%	14,636 $589,000
Q4 2020 Feb 02, 2021	BUY	$45.01 - $65.47 $660,881 - $961,296	14,683 New	14,683 $868,000

Others Institutions Holding ADPT

# of Institutions

246

Shares Held

156M

Call Options Held

44.3K

Put Options Held

47.8K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.74B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bouvel Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bouvel Investment Partners, LLC with notifications on news.

Account

Bouvel Investment Partners, LLC Adaptive Biotechnologies Corp Transaction History